Loading...
Omnicell, Inc.
OMCL•NASDAQ
Healthcare
Medical - Healthcare Information Services
$28.27
$0.14(0.50%)
Omnicell, Inc. (OMCL) Financial Performance & Income Statement Overview
Review Omnicell, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-3.04%
↓ 3.04%
Operating Income Growth
100.97%
↑ 100.97%
Net Income Growth
161.51%
↑ 161.51%
Operating Cash Flow Growth
3.66%
↑ 3.66%
Operating Margin
0.93%
↑ 0.93%
Gross Margin
43.08%
↑ 43.08%
Net Profit Margin
1.87%
↑ 1.87%
ROE
1.72%
↑ 1.72%
ROIC
0.68%
↑ 0.68%
Omnicell, Inc. (OMCL) Income Statement & Financial Overview
Review Omnicell, Inc.'s (OMCL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $306.88M | $282.42M | $276.79M | $246.15M |
| Cost of Revenue | $165.12M | $160.15M | $162.44M | $150.83M |
| Gross Profit | $141.76M | $122.27M | $114.35M | $95.32M |
| Gross Profit Ratio | $0.46 | $0.43 | $0.41 | $0.39 |
| R&D Expenses | $26.04M | $21.21M | $21.10M | $21.75M |
| SG&A Expenses | $103.33M | $94.49M | $90.03M | $92.26M |
| Operating Expenses | $129.37M | $115.70M | $111.13M | $114.003M |
| Total Costs & Expenses | $294.48M | $275.86M | $273.56M | $264.83M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $4.97M | $4.02M |
| Depreciation & Amortization | $22.21M | $0.00 | $22.81M | $23.18M |
| EBITDA | $34.61M | $6.56M | $26.03M | $1.34M |
| EBITDA Ratio | $0.11 | $0.02 | $0.09 | $0.005 |
| Operating Income | $12.40M | $6.56M | $3.22M | -$18.68M |
| Operating Income Ratio | $0.04 | $0.02 | $0.01 | -$0.08 |
| Other Income/Expenses (Net) | $11.20M | $5.06M | $4.97M | $4.02M |
| Income Before Tax | $23.60M | $11.63M | $8.20M | -$17.83M |
| Income Before Tax Ratio | $0.08 | $0.04 | $0.03 | -$0.07 |
| Income Tax Expense | $7.76M | $3.00M | $4.46M | -$2.15M |
| Net Income | $15.84M | $8.63M | $3.73M | -$15.68M |
| Net Income Ratio | $0.05 | $0.03 | $0.01 | -$0.06 |
| EPS | $0.34 | $0.19 | $0.08 | -$0.34 |
| Diluted EPS | $0.34 | $0.19 | $0.08 | -$0.34 |
| Weighted Avg Shares Outstanding | $46.34M | $46.15M | $45.95M | $45.73M |
| Weighted Avg Shares Outstanding (Diluted) | $46.85M | $46.43M | $46.04M | $45.73M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan